Tuesday, May 19, 2026
Today's Print

Tag: MOVe-OUT clinical trial

MSD starts enrollment for Phase 3 clinical trial of molnupiravir

MSD in the Philippines (tradename of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK) has announced the initiation of the Phase 3 portion...
- Advertisement -spot_img
- Advertisement -spot_img